Association between cyclooxygenase‐2‐expressing macrophages, ulceration and microvessel density in colorectal cancer
- 17 February 2005
- journal article
- Published by Wiley in Histopathology
- Vol. 46 (3), 287-295
- https://doi.org/10.1111/j.1365-2559.2005.02083.x
Abstract
In colorectal carcinomas, cyclooxygenase-2 (COX-2) is expressed predominantly by epithelial cells and is implicated in tumour progression. Tumour-associated macrophages may influence tumour growth, proliferative rate and angiogenesis and also express COX-2 when activated. Thus they may play an important stromal-epithelial role in carcinogenesis. Tauhe aim of this study was to define the relationship between microvessel density (MVD), tumour COX-2 and macrophage COX-2 expression. Sixty-five cases of formalin-fixed paraffin-embedded colorectal cancer were included in the study. Tissues were immunostained for COX-2, CD68 (macrophage marker) and CD34 (endothelial marker to assess MVD). Thirty-six cases were grossly ulcerated cancers and 29 cases showed focal/microscopic ulceration. Macrophages were in high concentration at the base of ulcerated areas, and were also diffusely dispersed within tumoral stroma. However, the pattern of macrophage COX-2 expression revealed two populations of macrophages--those deep within the tumour (negative for COX-2) and those at the base of ulcers (positive for COX-2). In all cases, the tumour epithelial cells expressed COX-2. MVD was higher at the base of ulcers, adjacent to COX-2+ macrophages, and was lower deep within the tumour. In colorectal cancers, macrophages may have a dual role. Those concentrated at the base of the ulcers, where there is an associated high MVD, may induce angiogenesis, but their function may be in a healing/repair process. The lack of COX-2+ macrophages and lower MVD deep within the tumour suggests that it may be the epithelial COX-2 component that is important in tumour progression.Keywords
This publication has 31 references indexed in Scilit:
- Interstitial cell cyclooxygenase‐2 expression is associated with increased angiogenesis in human sporadic colorectal adenomasThe Journal of Pathology, 2002
- Antiangiogenic Effect of a Highly Selective Cyclooxygenase-2 Inhibitor on Gastric Ulcer Healing in RatsToxicology and Applied Pharmacology, 2002
- MUCOSAL DEFENSE AND REPAIRGastroenterology Clinics of North America, 2001
- Role of cyclooxygenase-2 in gastric mucosal defenseLife Sciences, 2001
- Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinomaVirchows Archiv, 2001
- Cyclooxygenases: Structural, Cellular, and Molecular BiologyAnnual Review of Biochemistry, 2000
- Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL–10−/− miceGastroenterology, 2000
- Localization of Cyclooxygenase-2 in Human Sporadic Colorectal AdenomasThe American Journal of Pathology, 2000
- CYCLOOXYGENASE-2 INHIBITORS: A New Class of Anti-Inflammatory Agents That Spare the Gastrointestinal TractGastroenterology Clinics of North America, 1996
- The implications of angiogenesis for the biology and therapy of cancer metastasisCell, 1994